{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:54:02Z","timestamp":1790855642141,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Association of Vaasa, Vaasa, Finland"},{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0173855","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T17:59:31Z","timestamp":1489427971000},"page":"e0173855","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population"],"prefix":"10.1371","volume":"12","author":[{"given":"Aki Juhani","family":"K\u00e4r\u00e4j\u00e4m\u00e4ki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Kettunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuli","family":"Lepoj\u00e4rvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli-Pekka","family":"Koivurova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Antero","family":"Kes\u00e4niemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Huikuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavi","family":"Ukkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"AJ Czaja","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"17","key":"ref2","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.3748\/wjg.v21.i17.5138","article-title":"Reversibility and heritability of liver fibrosis: Implications for research and therapy","volume":"21","author":"HM Atta","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2014.03.019","article-title":"Identifying molecular factors that contribute to resolution of liver fibrosis","volume":"146","author":"JP Iredale","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.27981","article-title":"Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study","volume":"63","author":"EM Koehler","year":"2016","journal-title":"Hepatology"},{"issue":"9816","key":"ref5","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0140-6736(11)61514-6","article-title":"Atrial fibrillation","volume":"379","author":"GY Lip","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Y Miyasaka","year":"2006","journal-title":"Circulation"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"e0142937","DOI":"10.1371\/journal.pone.0142937","article-title":"Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)","volume":"10","author":"AJ Karajamaki","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"e57183","DOI":"10.1371\/journal.pone.0057183","article-title":"Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes","volume":"8","author":"G Targher","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","article-title":"Performance of transient elastography for the staging of liver fibrosis: a meta-analysis","volume":"134","author":"M Friedrich-Rust","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/17474124.2015.1007955","article-title":"Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications","volume":"9","author":"S Ballestri","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2796.1999.00429.x","article-title":"Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects","volume":"245","author":"AO Rantala","year":"1999","journal-title":"J Intern Med"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"RM Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ahj.2009.05.010","article-title":"Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study","volume":"158","author":"A Alonso","year":"2009","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"ref14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/pds.2317","article-title":"A systematic review of validated methods for identifying atrial fibrillation using administrative data","volume":"21","author":"PN Jensen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"AS Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2013.05.044","article-title":"From NAFLD in clinical practice to answers from guidelines","volume":"59","author":"F Nascimbeni","year":"2013","journal-title":"J Hepatol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1365-2036.2011.04668.x","article-title":"Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index","volume":"33","author":"S Petta","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"VW Wong","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"P Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"M Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"ref23","first-page":"295","article-title":"The Environment and Disease: Association Or Causation?","volume":"58","author":"AB HILL","year":"1965","journal-title":"Proc R Soc Med"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"UE Lee","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"SL Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"S Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"E Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fphys.2016.00017","article-title":"The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts","volume":"7","author":"S Liang","year":"2016","journal-title":"Front Physiol"},{"issue":"28","key":"ref29","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: a review","volume":"19","author":"V Sanchez-Valle","year":"2012","journal-title":"Curr Med Chem"},{"issue":"22","key":"ref30","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation","volume":"60","author":"Y Guo","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvv001","article-title":"Atrial fibrillation: effects beyond the atrium?","volume":"105","author":"RS Wijesurendra","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1540-8167.2010.01774.x","article-title":"Update on the association of inflammation and atrial fibrillation","volume":"21","author":"P Patel","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/hrt.2006.108688","article-title":"The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation","volume":"94","author":"EM Kallergis","year":"2008","journal-title":"Heart"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10554-015-0766-z","article-title":"Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammation","volume":"32","author":"P Joseph","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2013.04.019","article-title":"Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase","volume":"62","author":"JY Youn","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fphys.2012.00140","article-title":"NOX4-Dependent Hydrogen Peroxide Overproduction in Human Atrial Fibrillation and HL-1 Atrial Cells: Relationship to Hypertension","volume":"3","author":"J Zhang","year":"2012","journal-title":"Front Physiol"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/jpet.114.218370","article-title":"Functions of galectin-3 and its role in fibrotic diseases","volume":"351","author":"LC Li","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"ref38","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"NC Henderson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"47","key":"ref39","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.3748\/wjg.v19.i47.8831","article-title":"Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma","volume":"19","author":"ML Bacigalupo","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.amjcard.2014.12.021","article-title":"Effects of persistent atrial fibrillation on serum galectin-3 levels","volume":"115","author":"KM Gurses","year":"2015","journal-title":"Am J Cardiol"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ahj.2014.02.009","article-title":"Galectin 3 and incident atrial fibrillation in the community","volume":"167","author":"JE Ho","year":"2014","journal-title":"Am Heart J"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"e0123574","DOI":"10.1371\/journal.pone.0123574","article-title":"Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation","volume":"10","author":"J Kornej","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.clinbiochem.2015.04.021","article-title":"Galectin-3 in atrial fibrillation: Simple bystander, player or both?","volume":"48","author":"G Lippi","year":"2015","journal-title":"Clin Biochem"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/ehw119","article-title":"Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation","volume":"38","author":"HM Spronk","year":"2017","journal-title":"Eur Heart J"},{"issue":"9658","key":"ref45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"T Watson","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/europace\/euq346","article-title":"A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation","volume":"13","author":"R Fu","year":"2011","journal-title":"Europace"},{"issue":"8\u20139","key":"ref47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.clinre.2011.03.011","article-title":"The role of hypercoagulability in liver fibrogenesis","volume":"35","author":"QM Anstee","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"9","key":"ref48","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2011.04429.x","article-title":"Hypercoagulability in cirrhosis: causes and consequences","volume":"9","author":"A Tripodi","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"18","key":"ref49","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.3748\/wjg.v22.i18.4427","article-title":"Thrombin activation and liver inflammation in advanced hepatitis C virus infection","volume":"22","author":"E Gonzalez-Reimers","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"8","key":"ref50","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1538-7836.2008.03015.x","article-title":"Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies","volume":"6","author":"QM Anstee","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"G226","DOI":"10.1152\/ajpgi.00444.2007","article-title":"Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis","volume":"294","author":"A Rullier","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.24784","article-title":"Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells","volume":"55","author":"V Knight","year":"2012","journal-title":"Hepatology"},{"key":"ref53","first-page":"CD010542","article-title":"Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease","volume":"1","author":"CS Pavlov","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0173855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T18:39:49Z","timestamp":1540233589000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0173855"}},"subtitle":[],"editor":[{"given":"Gianfranco D.","family":"Alpini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0173855","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}